Schonfeld Strategic Advisors LLC Dexcom Inc Transaction History

Schonfeld Strategic Advisors LLC

  • $13.8 Billion
  • Q3 2024

A detailed history of Schonfeld Strategic Advisors LLC transactions in Dexcom Inc stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 11,372 shares of DXCM stock, worth $915,104. This represents 0.01% of its overall portfolio holdings.

Number of Shares
11,372
Previous 64,946 82.49%
Holding current value
$915,104
Previous $7.36 Million 89.65%
% of portfolio
0.01%
Previous 0.05%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$64.0 - $116.06 $3.43 Million - $6.22 Million
-53,574 Reduced 82.49%
11,372 $762,000
Q2 2024

Aug 14, 2024
BUY
$110.31 - $140.45 $651,270 - $829,216
5,904 Added 10.0%
64,946 $7.36 Million
Q1 2024

May 15, 2024
SELL
$114.22 - $140.1 $2.27 Million - $2.78 Million
-19,841 Reduced 25.15%
59,042 $8.19 Million
Q4 2023

Feb 14, 2024
SELL
$75.49 - $124.16 $17 Million - $27.9 Million
-224,764 Reduced 74.02%
78,883 $9.79 Million
Q3 2023

Nov 14, 2023
BUY
$86.06 - $137.93 $19.6 Million - $31.4 Million
227,445 Added 298.48%
303,647 $28.3 Million
Q2 2023

Aug 14, 2023
SELL
$112.47 - $130.98 $1.73 Million - $2.01 Million
-15,338 Reduced 16.76%
76,202 $9.79 Million
Q1 2023

May 15, 2023
BUY
$104.0 - $122.92 $3.4 Million - $4.02 Million
32,739 Added 55.68%
91,540 $10.6 Million
Q4 2022

Feb 14, 2023
BUY
$84.98 - $122.67 $3.45 Million - $4.98 Million
40,601 Added 223.08%
58,801 $6.66 Million
Q3 2022

Nov 14, 2022
SELL
$76.35 - $94.18 $3.5 Million - $4.32 Million
-45,860 Reduced 71.59%
18,200 $1.47 Million
Q2 2022

Aug 15, 2022
BUY
$67.99 - $132.89 $3.68 Million - $7.19 Million
54,129 Added 545.05%
64,060 $4.77 Million
Q1 2022

May 16, 2022
SELL
$94.08 - $130.2 $974,198 - $1.35 Million
-10,355 Reduced 51.05%
9,931 $5.08 Million
Q4 2021

Feb 14, 2022
BUY
$129.87 - $162.82 $1.02 Million - $1.28 Million
7,838 Added 62.97%
20,286 $10.9 Million
Q3 2021

Nov 16, 2021
BUY
$106.71 - $143.18 $798,831 - $1.07 Million
7,486 Added 150.87%
12,448 $6.81 Million
Q2 2021

Aug 16, 2021
BUY
$80.99 - $107.93 $231,793 - $308,895
2,862 Added 136.29%
4,962 $2.12 Million
Q1 2021

May 17, 2021
SELL
$84.79 - $104.74 $856,379 - $1.06 Million
-10,100 Reduced 82.79%
2,100 $755,000
Q4 2020

Feb 16, 2021
BUY
$78.0 - $104.5 $850,200 - $1.14 Million
10,900 Added 838.46%
12,200 $4.51 Million
Q3 2020

Nov 16, 2020
SELL
$95.51 - $112.95 $1.02 Million - $1.2 Million
-10,634 Reduced 89.11%
1,300 $536,000
Q2 2020

Aug 14, 2020
BUY
$62.68 - $105.34 $428,355 - $719,893
6,834 Added 134.0%
11,934 $4.84 Million
Q1 2020

May 15, 2020
SELL
$47.79 - $75.63 $34,217 - $54,151
-716 Reduced 12.31%
5,100 $1.37 Million
Q4 2019

Feb 14, 2020
SELL
$36.62 - $57.29 $753,822 - $1.18 Million
-20,585 Reduced 77.97%
5,816 $1.27 Million
Q3 2019

Nov 14, 2019
BUY
$35.53 - $43.8 $465,478 - $573,823
13,101 Added 98.5%
26,401 $3.94 Million
Q2 2019

Aug 14, 2019
SELL
$27.84 - $38.92 $1.73 Million - $2.42 Million
-62,100 Reduced 82.36%
13,300 $1.99 Million
Q1 2019

May 15, 2019
BUY
$28.07 - $38.18 $976,836 - $1.33 Million
34,800 Added 85.71%
75,400 $8.98 Million
Q4 2018

Feb 14, 2019
BUY
$26.99 - $37.37 $99,863 - $138,269
3,700 Added 10.03%
40,600 $4.86 Million
Q3 2018

Nov 14, 2018
BUY
$23.35 - $36.72 $665,241 - $1.05 Million
28,490 Added 338.76%
36,900 $5.28 Million
Q2 2018

Aug 14, 2018
SELL
$17.54 - $25.22 $402,946 - $579,379
-22,973 Reduced 73.2%
8,410 $799,000
Q1 2018

May 15, 2018
SELL
$13.06 - $18.54 $1.3 Million - $1.84 Million
-99,447 Reduced 76.01%
31,383 $2.33 Million
Q4 2017

Feb 14, 2018
BUY
$11.12 - $15.38 $380,748 - $526,611
34,240 Added 35.45%
130,830 $7.51 Million
Q3 2017

Nov 14, 2017
BUY
$11.36 - $18.98 $1.1 Million - $1.83 Million
96,590
96,590 $4.73 Million

Others Institutions Holding DXCM

# of Institutions
1,015
Shares Held
352M
Call Options Held
5.51M
Put Options Held
5.6M
View Full List

About DEXCOM INC

DXCM Quotes by TradingView
  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $31.1B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Schonfeld Strategic Advisors LLC Portfolio

Follow Schonfeld Strategic Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email